# Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children

> **NCT01273246** · PHASE1 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 132 (actual)

## Conditions studied

- Hand-foot-mouth Disease
- Infection; Viral, Enterovirus

## Interventions

- **BIOLOGICAL:** 100U inactivated Enterovirus Type 71 Vaccine
- **BIOLOGICAL:** 200U inactivated Enterovirus Type 71 Vaccine
- **BIOLOGICAL:** 400U inactivated Enterovirus Type 71 Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01273246
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-07
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273246, "Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01273246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*